A Phase Ib/II Clinical Study of BBI608 in Combination With Temozolomide for Adult Patients With Recurrent or Progressed Glioblastoma
This is an open label, multi-centre, phase 1 safety run-in and phase 2 study of BBI608 in
combination with temozolomide in patients with recurrent or progressive glioblastoma who
have not received prior bevacizumab therapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society